Date published: 2025-9-9

1-800-457-3801

SCBT Portrait Logo
Seach Input

WDR89 Inhibitors

Inhibitors of WDR89 function through a variety of mechanisms to dampen the activity of this protein, which is involved in cellular processes such as protein synthesis, cell growth, and survival. Certain compounds achieve this by targeting the mTOR pathway, a crucial signaling route for regulating protein synthesis and cell proliferation. By binding to proteins that interact with mTOR, these inhibitors can suppress the pathway's activity, leading to a consequential decrease in the functional dynamics of WDR89. Other inhibitors operate by obstructing the PI3K/AKT signaling cascade, which is integral to cellular survival. By halting PI3K or directly inhibiting AKT, these compounds ensure a downstream reduction in the activity of WDR89, which is linked to this pathway's outputs. Furthermore, the MAPK/ERK and p38 MAPK pathways, which play pivotal roles in cell proliferation, differentiation, and stress response, are also targeted by specific inhibitors. By selectively inhibiting kinases like MEK1/2, p38, or JNK within these pathways, the transduction of critical signals is impeded, leading to a subsequent decline in WDR89 activity. Some compounds exert their effects on the cytoskeletal architecture, which is fundamental for cell shape, motility, and intracellular transport, processes in which WDR89 may be involved either directly or indirectly through its association with other proteins. Disruption of cytoskeletal dynamics can therefore impair the correct localization and function of WDR89 within the cell. In addition, certain inhibitors may influence the ubiquitin-proteasome system, which regulates protein turnover. By modulating this system, these inhibitors can affect the stability and degradation rate of WDR89, leading to a reduced presence within the cell and a consequent decrease in its activity.

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

This compound binds to FKBP12 and together they inhibit the mTOR pathway, which is essential for protein synthesis and cell growth. Inhibition of this pathway leads to reduced activity of downstream proteins including WDR89, affecting its function.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

A specific inhibitor of PI3K, leading to suppression of the AKT signaling pathway. This cascade is crucial for cell survival and growth; by inhibiting PI3K, the downstream effects result in decreased activity of proteins like WDR89.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$63.00
$241.00
136
(2)

Acts as a selective inhibitor of MEK1/2, effectively blocking the MAPK/ERK pathway. This pathway is involved in cell proliferation and differentiation, and its inhibition disrupts the functional activity of proteins involved, such as WDR89.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

A p38 MAPK inhibitor that disrupts the p38 signaling pathway, which is involved in stress responses and cytokine production. Inhibiting this pathway impairs the activity of associated proteins, including WDR89.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$65.00
$267.00
257
(3)

An inhibitor of JNK, modulating the JNK signaling pathway which affects processes like apoptosis and inflammation. By inhibiting this pathway, proteins that participate in these processes, like WDR89, are rendered less active.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

A potent inhibitor of PI3K, leading to the cessation of the PI3K/AKT pathway. This interference results in a decrease in the functional activity of related proteins, such as WDR89.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

Specifically inhibits MEK, which is part of the MAPK/ERK pathway. Disruption of this pathway affects cell cycle progression and growth, indirectly leading to decreased activity of proteins such as WDR89 involved in these processes.

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$182.00
$693.00
88
(1)

A ROCK inhibitor that affects cytoskeleton organization and cell motility by inhibiting the Rho/ROCK pathway. This leads to a decrease in the activity of related proteins, including WDR89.

BIX 02189

1094614-85-3sc-364436
sc-364436A
5 mg
10 mg
$220.00
$378.00
5
(1)

Inhibits MEK5, which consequently affects the ERK5 pathway involved in cell proliferation and survival. By inhibiting this pathway, the activity of proteins involved in these processes, including WDR89, is decreased.

MLN 4924

905579-51-3sc-484814
1 mg
$280.00
1
(0)

This compound inhibits NEDD8-activating enzyme, which is essential for the neddylation process affecting protein degradation. By inhibiting this enzyme, the stability and function of proteins like WDR89 can be indirectly decreased.